Literature DB >> 1676046

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

M S Saag1, M J Crain, W D Decker, S Campbell-Hill, S Robinson, W E Brown, M Leuther, R J Whitley, B H Hahn, G M Shaw.   

Abstract

Sixty-eight adults and nine children infected with human immunodeficiency virus type 1 (HIV-1) were evaluated consecutively for the presence and amount of cell-free infectious virus in their plasma. Viremia was detected in 18 of 68 adults and in five of nine children; titers ranged from 10 to 100,000,000 TCID/ml plasma. Among the adults, none of 19 asymptomatic patients, 4 of 34 AIDS-related complex patients, and 14 of 15 AIDS patients had cell-free infectious virus in their plasma. None of 35 adult subjects with CD4+ lymphocyte counts greater than 400/mm3 were viremic, whereas 3 of 17 with 200-400 CD4+ lymphocytes/mm3 and 15 of 16 individuals with less than 200 CD4+ lymphocytes/mm3 were plasma viremic. In contrast to adults, each of five children infected with HIV-1 in utero or during the perinatal period were plasma viremic regardless of their CD4+ lymphocytes counts (range, 42-2227/mm3), duration of infection, or clinical stage; however, children infected by HIV-1 at older ages were less frequently plasma viremic. Therapy with zidovudine led to a 10- to 10(6)-fold decline in plasma HIV-1 TCID in all eight subjects studied before and after treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676046     DOI: 10.1093/infdis/164.1.72

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques.

Authors:  A M Scharko; S B Perlman; J M Hanson; H Uno; C D Pauza
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.

Authors:  H Kaneshima; L Su; M L Bonyhadi; R I Connor; D D Ho; J M McCune
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  J B McMahon; R J Gulakowski; O S Weislow; R J Schultz; V L Narayanan; D J Clanton; R Pedemonte; F W Wassmundt; R W Buckheit; W D Decker
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  Maintaining confidentiality in a look-back investigation of patients treated by a HIV-infected dentist.

Authors:  P M Arnow; T Chou; R Shapiro; E J Sussman
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

5.  Survival of human immunodeficiency virus (HIV), HIV-infected lymphocytes, and poliovirus in water.

Authors:  B E Moore
Journal:  Appl Environ Microbiol       Date:  1993-05       Impact factor: 4.792

6.  Prospective study of antigenemia, plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs.

Authors:  S Melón Garcia; M de Oña Navarro; C Rodriguez Pinto; M Fernández Urgellés; A Martinez Gutierrez; P de la Iglesia; F J Mendez García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

7.  Feline immunodeficiency virus: quantification in peripheral blood mononuclear cells and isolation from plasma of infected cats.

Authors:  J Meers; W F Robinson; G M del Fierro; M A Scoones; M A Lawson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

Authors:  K K Van Rompay; M G Otsyula; M L Marthas; C J Miller; M B McChesney; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

Authors:  R I Connor; H Mohri; Y Cao; D D Ho
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.